Tradestie Institutional Equity Comparison Engine

SKIN vs HNST โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

HNST Overall Edge

HNST Captures Institutional Edge (3โ€“1 Pillars ยท 7โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to The Honest Company, Inc. Common Stock (HNST) driven by superior Valuation, Growth & Margin, Options & Structure while SKIN counters with relative strength in Momentum & Technical. Fundamentally, SKIN trades at 106.4x Forward P/E with 2.4% operating margin (-2.1% YoY revenue) versus HNST at 43.5x Forward P/E and 2.4% operating margin (-8.6% YoY). In options structure, SKIN sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro) against HNST sits in CONSOLIDATION (7th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner HNST
SKIN 106.4x vs HNST 43.5x Fwd P/E
Growth & Margin Winner HNST
Op Margin 2.4% vs 2.4% ยท YoY -2.1% vs -8.6%
Momentum & Technical Winner SKIN
1Y +1057.7% vs +88.2% ยท 52W Pos 83% vs 71%
Options & Structure Winner HNST
UNCLASSIFIED (100th %ile IV) vs CONSOLIDATION (7th %ile IV)
SKIN NASDAQ
The Beauty Health Company Class A Common Stock
Surgical & Medical Instruments & Apparatus
$15.05
-7.73% 1D
Market Cap $106.3M
1M Return +42.52%
1Y Return +1057.69%
Forward P/E 106.4x
Unified AI Score
34.1 / 100 SELL
Tech 50.0 Fund 34.0 Flow 67.0 Mom 46.0
HNST NASDAQ
The Honest Company, Inc. Common Stock
Retail-Catalog & Mail-Order Houses
$4.88
-2.79% 1D
Market Cap $547.1M
1M Return -2.5%
1Y Return +88.22%
Forward P/E 43.5x
Unified AI Score
36.7 / 100 SELL
Tech 17.0 Fund 46.0 Flow 70.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: SKIN +1057.69% HNST +88.22% Spread: +969.47 pp (SKIN Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period SKIN Revenue HNST Revenue SKIN Op. Margin HNST Op. Margin Margin Edge
FY2019 $170M $240M 8.1% -13.4% SKIN
FY2020 $120M $300M -14.4% -4.5% HNST
FY2021 $260M $320M -15.4% -11.6% HNST
FY2022 $370M $310M -7.1% -15.9% SKIN
FY2023 $400M $340M -32.9% -11.3% HNST
FY2024 $330M $380M -20.3% -1.7% HNST
FY2025 $300M $370M -6.9% -5.0% HNST

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: SKIN (2) vs HNST (7)
Institutional Metric SKIN HNST Criterion Row Winner
Market Capitalization Scale $106.3M $547.1M Larger Scale HNST
Trailing P/E Ratio Valuation 106.4x 7.3x Lower Multiple HNST
Forward P/E Ratio Valuation 106.4x 43.5x Lower Multiple HNST
Revenue Growth (YoY) Growth -2.1% -8.6% Higher Growth SKIN
Operating Margin (TTM) Profitability 2.4% 2.4% Higher Margin Tie
Net Profit Margin Profitability -6.3% 23.5% Higher Margin HNST
Return on Equity (ROE) Capital Efficiency -30.1% 34.6% Higher ROE HNST
52-Week Range Position Momentum 83% ($0โ€“$18) 71% ($2โ€“$6) Stronger Trend SKIN
Beta / 30D Volatility Risk Regime -14.22ฮฒ ยท 192% Vol 1.09ฮฒ ยท 66% Vol Lower Realized Risk HNST
Unified Institutional Score Composite Signal 34.1 / 100 (SELL) 36.7 / 100 (SELL) Higher Composite HNST

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full SKIN vs HNST Buy Guide
SKIN UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 100th %ile
IV Regime Extreme (>80th %ile)
Live SKIN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
HNST CONSOLIDATION
56d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 7th %ile
IV Regime Compressed (<25th %ile)
Live HNST Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither SKIN nor HNST registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.